ICU Medical, Inc. develops, manufactures and sells medical devices used in infusion therapy and critical care applications worldwide. The company is headquartered in San Clemente, California.
| Revenue (TTM) | $2.23B |
| Gross Profit (TTM) | $822.04M |
| EBITDA | $310.07M |
| Operating Margin | 4.82% |
| Return on Equity | 0.04% |
| Return on Assets | 1.66% |
| Revenue/Share (TTM) | $90.55 |
| Book Value | $86.03 |
| Price-to-Book | 1.43 |
| Price-to-Sales (TTM) | 1.34 |
| EV/Revenue | 1.821 |
| EV/EBITDA | 13.61 |
| Quarterly Earnings Growth (YoY) | -23.80% |
| Quarterly Revenue Growth (YoY) | -14.10% |
| Shares Outstanding | $24.99M |
| Float | $23.75M |
| % Insiders | 3.52% |
| % Institutions | 114.73% |